过氧化物酶体增殖物激活受体γ调控微RNA-223水平改善高脂诱导胰岛素抵抗细胞糖吸收障碍
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.1

基金项目:

上海市浦东新区卫生科技发展委基金(PKJ2018-Y09),上海市浦东新区卫生系统优秀青年医学人才培养计划(PWRq2020-61,PWRq-2020-63),上海市卫生健康委员会青年项目(20204Y0144),上海市浦东新区重点亚专科项目(PWZy2020-06),上海市浦东新区临床特色学科项目(PWYts2021-15).


Role of peroxisome proliferators-activated receptor γ in improving glucose absorption disorders in high-fat induced insulin resistance cells by regulating microRNA-223
Author:
Affiliation:

Fund Project:

Supported by Shanghai Pudong New Area Science and Technology Innovation Project (PKJ2018-Y09), Shanghai Pudong New Area Youth Talent Project in Medicine (PWRq2020-61, PWRq-2020-63), Youth Project of Shanghai Municipal Health Commission (20204Y0144), Shanghai Pudong New Area Key Subspecialty Project (PWZy2020-06), and Shanghai Pudong New Area Clinical Characteristic Discipline Project (PWYts2021-15).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 观察过氧化物酶体增殖物激活受体γ(PPARγ)调控miRNA-223水平在高脂诱导的胰岛素抵抗中的作用。方法 Wistar雄性大鼠通过高脂饲料喂养,建立2型糖尿病动物模型并予以吡格列酮治疗,以qPCR、葡萄糖氧化酶-过氧化物酶法和ELISA法检测吡格列酮治疗前后2型糖尿病大鼠血清miRNA-223、血糖及4种炎症因子(IL-1β、IL-6、IL-8、TNF-α)水平的变化;以软脂酸诱导HepG2细胞胰岛素抵抗模型,上调或抑制PPARγ蛋白或miRNA-223水平后,以细胞葡萄糖吸收实验、蛋白质印迹法和qPCR法检测细胞葡萄糖吸收水平、细胞葡萄糖转运蛋白(葡萄糖转运蛋白1、2、4;胰岛素受体底物1、2)表达及miRNA-223水平的变化。结果 与治疗前相比,吡格列酮治疗7 d后大鼠空腹血糖水平下降、血清miRNA-223水平上升、血清炎症因子(IL-1β、IL-6、IL-8、TNF-α)相对表达量下降(P均<0.001)。经软脂酸处理24 h后,软脂酸组HepG2细胞PPARγ蛋白表达和miRNA-223水平均较空白对照组降低,且细胞葡萄糖吸收水平下降(P均<0.05);上调PPARγ蛋白可改善软脂酸导致的细胞葡萄糖吸收水平下降、升高miRNA-223及炎症因子水平(P均<0.05)。抑制PPARγ表达可导致细胞葡萄糖吸收水平降低(P<0.05)、miRNA-223表达水平下降(P<0.05),但对正常状态下炎症因子水平无调节作用;过表达miRNA-223可改善软脂酸诱导的细胞葡萄糖吸收水平下降和炎症因子水平增高(P均<0.05),以及上调葡萄糖转运蛋白1、葡萄糖转运蛋白4、胰岛素受体底物1的表达(P均<0.05);抑制miRNA-223对软脂酸诱导的细胞葡萄糖吸收水平及葡萄糖转运蛋白1、葡萄糖转运蛋白4、胰岛素受体底物1表达的作用与过表达miRNA-223效果相反(P均<0.05)。但过表达或抑制miRNA-223均对PPARγ表达无影响。结论 PPARγ通过调节miRNA-223水平改善高脂诱导的胰岛素抵抗细胞葡萄糖吸收。

    Abstract:

    Objective To investigate the role of peroxisome proliferators-activated receptors γ (PPARγ) in hight-fat induced insulin resistance by regulating microRNA (miRNA)-223. Methods The rat model of type 2 diabetes mellitus was established by feeding high-fat diet and treated with pioglitazone. Serum miRNA-223, blood glucose and 4 inflammatory factors (interleukin[IL]-1β, IL-6, IL-8, and tumor necrosis factor α[TNF-α]) in type 2 diabetes mellitus rats before and after treatment were detected by quantitative polymerase chain reaction (qPCR), glucose oxidase peroxidase and enzyme-linked immunosorbent assay. In a model of insulin resistance in HepG2 cells induced by palmitic acid, the levels of PPARγ or miRNA-223 were upregulated or inhibited, and the level of cellular glucose absorbtion, expression of cell glucose transporters (glucose transporters 1, 2, 4; insulin receptor substrates 1, 2) and miRNA-223 level were detected by Cell glucose absorption experiment, Western blotting and qPCR, respectively. Results Compared with that before pioglitazone treatment, the fasting blood glucose level of rats and the expression of serum inflammatory factors (IL-1β, IL-6, IL-8, and TNF-α) were significantly decreased and the level of serum miRNA-223 was significantly increased after 7 d of pioglitazone treatment (all P<0.001). After 24-h treatment with palmitic acid, the expression of PPARγ protein, miRNA-223 level and glucose absorption level of HepG2 cells were significantly decreased (all P<0.05). Upregulation of PPARγ protein could ameliorate the decrease of cellular glucose absorption induced by palmitic acid and increase the levels of miRNA-223 and inflammatory factors (all P<0.05). Inhibition of PPARγ expression resulted in decreased glucose absorption (P<0.05) and decreased miRNA-223 level (P<0.05), but there was no regulatory effect on the level of inflammatory factors in normal cells. Overexpression of miRNA-223 could improve the palmitic acid-induced decrease of glucose absorption and the increase of inflammatory factors (both P<0.05), as well as up-regulate the expression of glucose transporters (glucose transporters 1, 4) and insulin receptor substrate 1 (all P<0.05). Inhibition of miRNA-223 had an opposite effect of overexpression of miRNA-223 on the level of PA-induced cellular glucose uptake and expression of glucose transporter protein 1, glucose transporter protein 4, and insulin receptor substrate 1 (all P<0.05). However, overexpression or inhibition of miRNA-223 did not affect the expression of PPARγ. Conclusion PPARγ can improve glucose absorption of insulin resistance cells induced by high fat by regulating miRNA-223.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-08-13
  • 最后修改日期:2021-12-07
  • 录用日期:
  • 在线发布日期: 2023-01-12
  • 出版日期: 2022-11-20
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭